114 related articles for article (PubMed ID: 7929419)
21. Truncated c-Myb expression in the human leukemia cell line TK-6.
Tomita A; Watanabe T; Kosugi H; Ohashi H; Uchida T; Kinoshita T; Mizutani S; Hotta T; Murate T; Seto M; Saito H
Leukemia; 1998 Sep; 12(9):1422-9. PubMed ID: 9737692
[TBL] [Abstract][Full Text] [Related]
22. Myb binding sites mediate negative regulation of c-myb expression in T-cell lines.
Guerra J; Withers DA; Boxer LM
Blood; 1995 Sep; 86(5):1873-80. PubMed ID: 7655015
[TBL] [Abstract][Full Text] [Related]
23. Murine myeloid leukemic cells with disrupted myb loci show splicing anomalies that account for heterogeneous sizes in myb proteins.
Tantravahi R; Dudek H; Patel G; Reddy EP
Oncogene; 1996 Sep; 13(6):1187-96. PubMed ID: 8808693
[TBL] [Abstract][Full Text] [Related]
24. Characterization of differentially expressed genes in the bovine T lymphoma cell line.
Onodera H; Ishiguro N; Horiuchi M; Shinagawa M
Vet Immunol Immunopathol; 1998 Apr; 62(3):209-19. PubMed ID: 9643455
[TBL] [Abstract][Full Text] [Related]
25. Regulation of c-myb oncogene expression in immature and mature murine T cells.
Mountz JD; Subler MA
Mol Immunol; 1993 Jun; 30(9):787-95. PubMed ID: 8321245
[TBL] [Abstract][Full Text] [Related]
26. A 5'-CG-3'-rich region in the promoter of the transcriptionally frequently silenced RET protooncogene lacks methylated cytidine residues.
Munnes M; Patrone G; Schmitz B; Romeo G; Doerfler W
Oncogene; 1998 Nov; 17(20):2573-83. PubMed ID: 9840920
[TBL] [Abstract][Full Text] [Related]
27. Interaction of the v-and c-Myb proteins with regulatory sequences of the human c-myc gene.
Zobel A; Kalkbrenner F; Guehmann S; Nawrath M; Vorbrueggen G; Moelling K
Oncogene; 1991 Aug; 6(8):1397-407. PubMed ID: 1679531
[TBL] [Abstract][Full Text] [Related]
28. DNA binding and transactivation activity of A-myb, a c-myb-related gene.
Ma XP; Calabretta B
Cancer Res; 1994 Dec; 54(24):6512-6. PubMed ID: 7987850
[TBL] [Abstract][Full Text] [Related]
29. Human c-myb is expressed in cervical carcinomas and transactivates the HPV-16 promoter.
Nürnberg W; Artuc M; Nawrath M; Lovric J; Stüting S; Moelling K; Czarnetzki BM; Schadendorf D
Cancer Res; 1995 Oct; 55(19):4432-7. PubMed ID: 7671256
[TBL] [Abstract][Full Text] [Related]
30. Identification of an inducible regulator of c-myb expression during T-cell activation.
Phan SC; Feeley B; Withers D; Boxer LM
Mol Cell Biol; 1996 May; 16(5):2387-93. PubMed ID: 8628306
[TBL] [Abstract][Full Text] [Related]
31. Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene.
Chen J; Lin J; Levine AJ
Mol Med; 1995 Jan; 1(2):142-52. PubMed ID: 8529093
[TBL] [Abstract][Full Text] [Related]
32. Functional analysis of c-Myb protein in T-lymphocytic cell lines shows that it trans-activates the c-myc promoter.
Evans JL; Moore TL; Kuehl WM; Bender T; Ting JP
Mol Cell Biol; 1990 Nov; 10(11):5747-52. PubMed ID: 2233716
[TBL] [Abstract][Full Text] [Related]
33. Two modes of c-myb activation in virus-induced mouse myeloid tumors.
Shen-Ong GL; Morse HC; Potter M; Mushinski JF
Mol Cell Biol; 1986 Feb; 6(2):380-92. PubMed ID: 3023843
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of C-terminally but not N-terminally truncated Myb induces fibrosarcomas: a novel nonhematopoietic target cell for the myb oncogene.
Press RD; Reddy EP; Ewert DL
Mol Cell Biol; 1994 Apr; 14(4):2278-90. PubMed ID: 8139533
[TBL] [Abstract][Full Text] [Related]
35. Mutations in the interferon-sensitivity determining region of hepatitis C virus and transcriptional activity of the nonstructural region 5A protein.
Fukuma T; Enomoto N; Marumo F; Sato C
Hepatology; 1998 Oct; 28(4):1147-53. PubMed ID: 9755255
[TBL] [Abstract][Full Text] [Related]
36. Transcriptional activation by the v-myb oncogene and its cellular progenitor, c-myb.
Weston K; Bishop JM
Cell; 1989 Jul; 58(1):85-93. PubMed ID: 2665942
[TBL] [Abstract][Full Text] [Related]
37. Identification of a second promoter in the human c-myb proto-oncogene.
Jacobs SM; Gorse KM; Westin EH
Oncogene; 1994 Jan; 9(1):227-35. PubMed ID: 8302584
[TBL] [Abstract][Full Text] [Related]
38. Alternative splicing of the human c-myb gene.
Westin EH; Gorse KM; Clarke MF
Oncogene; 1990 Aug; 5(8):1117-24. PubMed ID: 2202948
[TBL] [Abstract][Full Text] [Related]
39. An inhibitory carboxyl-terminal domain in Ets-1 and Ets-2 mediates differential binding of ETS family factors to promoter sequences of the mb-1 gene.
Hagman J; Grosschedl R
Proc Natl Acad Sci U S A; 1992 Oct; 89(19):8889-93. PubMed ID: 1409581
[TBL] [Abstract][Full Text] [Related]
40. Differential binding of nuclear factors to the intron 1 sequences containing the transcriptional pause site correlates with c-myb expression.
Reddy CD; Reddy EP
Proc Natl Acad Sci U S A; 1989 Oct; 86(19):7326-30. PubMed ID: 2678098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
